Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2021-07-01
2022-11-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
REmote Assessment and Dynamic Response Intervention
NCT04542109
Resilient Together for Dementia
NCT06421545
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
NCT05733520
Innovations in Dementia Empowerment and Action
NCT03550131
The Brain Health Study: A Pragmatic, Patient-Centered Trial
NCT05356702
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
People who voluntarily decide to participate in this follow-up intervention study will be asked to continue participating with the in-home monitoring sensor platform, complete weekly questionnaires, and receive regular follow-up telephone calls from the study team.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
READyR II A
Continuous monitoring will be conducted and analyzed for anomaly detection. Participants in this arm will receive contact phone call when a potential change in care needs is indicated by an anomaly.
READyR II: A
Continuous monitoring for anomaly detection and contact phone call when a potential change in care needs is indicated by an anomaly.
READyR II B (comparison)
Sensors will remain in the home but anomaly detection analysis will not be performed and contact phone calls will be at regular intervals without dynamic tailoring content. Standard educational content will instead be shared over the phone.
READyR II: B
Sensors will remain in the home but anomaly detection analysis will not be performed and contact phone calls will be at regular intervals without dynamic tailoring content.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
READyR II: A
Continuous monitoring for anomaly detection and contact phone call when a potential change in care needs is indicated by an anomaly.
READyR II: B
Sensors will remain in the home but anomaly detection analysis will not be performed and contact phone calls will be at regular intervals without dynamic tailoring content.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to identify a family care partner over age 20 who is living with you and will also consent to fully participate in the study
* Probable or confirmed diagnosis of mild cognitive impairment or early-stage dementia
* Age and education adjusted MOCA score \> 15 (at most recent measurement by parent study) corresponding to early to moderate stage dementia
Exclusion Criteria
* Conditions that would limit participation at entry to study (e.g. visual or hearing impairments prohibiting reading and discussing the intervention materials)
* Any uncontrolled medical condition that is expected to preclude completion of the study, such as late stage cancers
Family Care Partners
Inclusion:
* 21 years or older;
* Self-identifying as a family member and care partner residing with the PwD participant;
Exclusion:
* Inability to speak English or read printed materials in English
* Conditions that would limit participation at entry to study (e.g. visual or hearing impairments prohibiting reading and discussing the intervention materials);
* Any uncontrolled medical condition that is expected to preclude completion of the study, such as late stage cancers.
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Oregon Health and Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lyndsey Miller
Co-Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lyndsey M Miller, PhD
Role: PRINCIPAL_INVESTIGATOR
Oregon Health and Science University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oregon Health & Science University
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.